Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Diltiazem Hydrochloride

Diltiazem Hydrochloride

0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US1 NDCs
0 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3443
US makers1 labelers
Packages1
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a204060812025 Q12025 Q22025 Q32025 Q42026 Q1
30
Rx · 2025 Q4
72
Units dispensed
4
Quarters · since 2025 Q1

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Hospira, Inc.unknown1EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 5, 2026
    RESOLVEDShortage resolved: Diltiazem Hydrochloride Injection (Hospira, Inc., a Pfizer Company)

    Diltiazem Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.

  • Jan 5, 2026
    SHORTAGEDrug shortage: Diltiazem Hydrochloride Injection (Hospira, Inc., a Pfizer Company)

    Diltiazem Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Cardiovascular.